NO20083171L - Ny samling av HCDR3 omrader og anvendelser derav - Google Patents
Ny samling av HCDR3 omrader og anvendelser deravInfo
- Publication number
- NO20083171L NO20083171L NO20083171A NO20083171A NO20083171L NO 20083171 L NO20083171 L NO 20083171L NO 20083171 A NO20083171 A NO 20083171A NO 20083171 A NO20083171 A NO 20083171A NO 20083171 L NO20083171 L NO 20083171L
- Authority
- NO
- Norway
- Prior art keywords
- hcdr3
- collection
- present
- members
- antibody
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Den foreliggende oppfinnelsen er rettet mot fremstillingen og anvendelsen av en samling av antistoff tungkjede komplementaritetsbestemmende område 3 (HCDR3)-medlemmer, hvor diversitet av samlingen er en funksjon av lengden av HCDR3 medlemmene. Diversiteten av samlingen av HCDR3-områder representerer vesentlig den naturlige aminosyredistribusjonen av HCDR3 i det humane repertoaret. Denne naturlige aminosyredistribusjonen kan bli representert ved å påvirke den fullstendige tilfeldige distribusjonen av aminosyrer, følgelig, i den HCDR3-kodende DNA sekvensen ved å anvende trinukleotide mutagenese (TRIM) teknologi. En samling av HCDR3 medlemmer av den foreliggende oppfinnelsen kan hver være omfattet innen et variabelt område av et antistoff (eller fragment derav) for å danne et bibliotek av syntetiske antistoffer eller antistoffragmenter. Syntetiske antistoffbiblioteker av den foreliggende oppfinnelsen kan bli designet til å inkludere modulære trekk, slik som kjemisk syntetiserte "mastergen" rammeverkområder, som kan inneholde unike restriksjonsseter som flankerer et eller flere CDR-områder, inkludert et HCDR3-område fremstilt som beskrevet heri. Den foreliggende oppfinnelsen fremskaffer også nukleinsyremolekyler som koder for slik forskjellig samling og fremgangsmåter for å fremstille og anvende det samme.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75163305P | 2005-12-20 | 2005-12-20 | |
| PCT/IB2006/004301 WO2008053275A2 (en) | 2005-12-20 | 2006-12-15 | Novel collection of hcdr3 regions and uses therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20083171L true NO20083171L (no) | 2008-08-27 |
Family
ID=39273832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20083171A NO20083171L (no) | 2005-12-20 | 2008-07-18 | Ny samling av HCDR3 omrader og anvendelser derav |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8273688B2 (no) |
| EP (1) | EP1979378B1 (no) |
| JP (1) | JP5405831B2 (no) |
| KR (1) | KR20080080653A (no) |
| CN (1) | CN101389655B (no) |
| AU (1) | AU2006350452B2 (no) |
| CA (1) | CA2634387C (no) |
| DK (1) | DK1979378T3 (no) |
| ES (1) | ES2394722T3 (no) |
| IL (1) | IL192315A0 (no) |
| MX (1) | MX2008008220A (no) |
| NO (1) | NO20083171L (no) |
| NZ (1) | NZ569359A (no) |
| WO (1) | WO2008053275A2 (no) |
| ZA (1) | ZA200806016B (no) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8288322B2 (en) | 2000-04-17 | 2012-10-16 | Dyax Corp. | Methods of constructing libraries comprising displayed and/or expressed members of a diverse family of peptides, polypeptides or proteins and the novel libraries |
| US20030133939A1 (en) * | 2001-01-17 | 2003-07-17 | Genecraft, Inc. | Binding domain-immunoglobulin fusion proteins |
| US7829084B2 (en) * | 2001-01-17 | 2010-11-09 | Trubion Pharmaceuticals, Inc. | Binding constructs and methods for use thereof |
| US7754208B2 (en) * | 2001-01-17 | 2010-07-13 | Trubion Pharmaceuticals, Inc. | Binding domain-immunoglobulin fusion proteins |
| US20040067532A1 (en) | 2002-08-12 | 2004-04-08 | Genetastix Corporation | High throughput generation and affinity maturation of humanized antibody |
| PT2298815E (pt) * | 2005-07-25 | 2015-07-16 | Emergent Product Dev Seattle | Moléculas de ligaçao especificas para cd37 e especificas para cd20 |
| MX2008015524A (es) * | 2006-06-12 | 2009-01-13 | Trubion Pharmaceuticals Inc | Proteinas de union multivalentes monocatenarias con funcion efectora. |
| US8691730B2 (en) | 2007-09-14 | 2014-04-08 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| US8877688B2 (en) | 2007-09-14 | 2014-11-04 | Adimab, Llc | Rationally designed, synthetic antibody libraries and uses therefor |
| EP2098536A1 (en) | 2008-03-05 | 2009-09-09 | 4-Antibody AG | Isolation and identification of antigen- or ligand-specific binding proteins |
| WO2009114815A1 (en) | 2008-03-13 | 2009-09-17 | Dyax Corp | Libraries of genetic packages comprising novel hc cdr3 designs |
| WO2009126944A1 (en) | 2008-04-11 | 2009-10-15 | Trubion Pharmaceuticals, Inc. | Cd37 immunotherapeutic and combination with bifunctional chemotherapeutic thereof |
| ES2528963T3 (es) | 2008-04-24 | 2015-02-13 | Dyax Corp. | Bibliotecas de paquetes genéticos que comprenden nuevos diseños de CDR1, CDR2, y CDR3 de HC y nuevos diseños de CDR1, CDR2, y CDR3 de LC |
| MX2011012696A (es) | 2009-05-29 | 2012-03-29 | Morphosys Ag | Una coleccion y metodos para su uso. |
| WO2011032181A2 (en) * | 2009-09-14 | 2011-03-17 | Dyax Corp. | Libraries of genetic packages comprising novel hc cdr3 designs |
| CN105734678B (zh) | 2010-07-16 | 2019-11-05 | 阿迪马布有限责任公司 | 合成多核苷酸文库 |
| SG189950A1 (en) | 2010-11-19 | 2013-06-28 | Morphosys Ag | A collection and methods for its use |
| MY197562A (en) | 2015-09-21 | 2023-06-23 | Aptevo Res & Development Llc | Cd3 binding polypeptides |
| CN105274630A (zh) * | 2015-11-25 | 2016-01-27 | 苏州泓迅生物科技有限公司 | 基于组合合成技术合成可控的人源化抗体库的方法与应用 |
| JP6959260B2 (ja) * | 2016-01-19 | 2021-11-02 | ズムトール バイオロジクス、インコーポレイテッド | 合成抗体ライブラリーを作製する方法、前記ライブラリー、及びその適用 |
| EP3293293A1 (en) | 2016-09-08 | 2018-03-14 | Italfarmaco SpA | Hc-cdr3-only libraries with reduced combinatorial redundancy and optimized loop length distribution |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6706484B1 (en) * | 1995-08-18 | 2004-03-16 | Morphosys Ag | Protein/(poly)peptide libraries |
| JP4436457B2 (ja) * | 1995-08-18 | 2010-03-24 | モルフォシス アイピー ゲーエムベーハー | 蛋白質／（ポリ）ペプチドライブラリー |
| DE60041119D1 (de) * | 1999-07-20 | 2009-01-29 | Morphosys Ag | Verfahren zur präsentation von (poly)peptiden/proteinen auf bakteriophagenpartikeln via disulfidbindungen |
| PT2316940E (pt) * | 2000-12-18 | 2013-10-16 | Dyax Corp | Bibliotecas orientadas de pacotes genéticos |
-
2006
- 2006-12-15 EP EP06851829A patent/EP1979378B1/en active Active
- 2006-12-15 AU AU2006350452A patent/AU2006350452B2/en active Active
- 2006-12-15 CA CA2634387A patent/CA2634387C/en active Active
- 2006-12-15 WO PCT/IB2006/004301 patent/WO2008053275A2/en active Application Filing
- 2006-12-15 JP JP2008546696A patent/JP5405831B2/ja active Active
- 2006-12-15 DK DK06851829.9T patent/DK1979378T3/da active
- 2006-12-15 ES ES06851829T patent/ES2394722T3/es active Active
- 2006-12-15 KR KR1020087017753A patent/KR20080080653A/ko not_active Application Discontinuation
- 2006-12-15 MX MX2008008220A patent/MX2008008220A/es not_active Application Discontinuation
- 2006-12-15 CN CN2006800530247A patent/CN101389655B/zh active Active
- 2006-12-15 NZ NZ569359A patent/NZ569359A/en unknown
- 2006-12-15 US US12/158,181 patent/US8273688B2/en active Active
-
2008
- 2008-06-19 IL IL192315A patent/IL192315A0/en unknown
- 2008-07-10 ZA ZA200806016A patent/ZA200806016B/xx unknown
- 2008-07-18 NO NO20083171A patent/NO20083171L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| US8273688B2 (en) | 2012-09-25 |
| AU2006350452B2 (en) | 2012-10-25 |
| MX2008008220A (es) | 2009-03-04 |
| CN101389655A (zh) | 2009-03-18 |
| DK1979378T3 (da) | 2012-10-29 |
| EP1979378A2 (en) | 2008-10-15 |
| CA2634387A1 (en) | 2008-05-08 |
| ES2394722T3 (es) | 2013-02-05 |
| JP2009519727A (ja) | 2009-05-21 |
| KR20080080653A (ko) | 2008-09-04 |
| IL192315A0 (en) | 2008-12-29 |
| CN101389655B (zh) | 2013-05-22 |
| JP5405831B2 (ja) | 2014-02-05 |
| EP1979378B1 (en) | 2012-07-25 |
| AU2006350452A1 (en) | 2008-05-08 |
| WO2008053275A3 (en) | 2008-08-21 |
| ZA200806016B (en) | 2009-07-29 |
| CA2634387C (en) | 2015-11-24 |
| WO2008053275A2 (en) | 2008-05-08 |
| NZ569359A (en) | 2011-11-25 |
| US20090088346A1 (en) | 2009-04-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20083171L (no) | Ny samling av HCDR3 omrader og anvendelser derav | |
| Saeed et al. | Antibody engineering for pursuing a healthier future | |
| EP3202786A3 (en) | Sequence based engineering and optimization of single chain antibodies | |
| SG163554A1 (en) | Human monoclonal antibodies to programmed death ligand 1 (pd-l1) | |
| WO2009000098A3 (en) | Sequence based engineering and optimization of single chain antibodies | |
| CN106605228B (zh) | 计算蛋白质设计的方法 | |
| Vant-Hull et al. | The mathematics of SELEX against complex targets | |
| WO2007067730A3 (en) | Human monoclonal antibodies to protein tyrosine kinase 7 ( ptk7 ) and their use | |
| NZ717429A (en) | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly | |
| WO2007067992A3 (en) | Human monoclonal antibodies to fucosyl-gm1 and methods for using anti-fucosyl-gm1 | |
| WO2008076560A3 (en) | Human monoclonal antibodies to btla and methods of use | |
| Mersmann et al. | Towards proteome scale antibody selections using phage display | |
| EP2439273A3 (en) | Human monoclonal antibodies to programmed death 1(PD-1) and methods for treating cancer using anti-PD-1 antibodies alone or in combination with other immunotherapeutics | |
| EP1994142A4 (en) | METHODS AND COMPOSITIONS FOR RAPID ISOLATION OF SMALL RNA MOLECULES | |
| WO2006068975A3 (en) | Binding proteins specific for human matriptase | |
| AU2003261168A1 (en) | Strategies for gene expression analysis | |
| DE602005027737D1 (de) | Verfahren zur antikörpererzeugung | |
| Kaltenbach et al. | SNAP dendrimers: Multivalent protein display on dendrimer‐like DNA for directed evolution | |
| Zumrut et al. | Ligand-guided selection with artificially expanded genetic information systems against TCR-CD3ε | |
| WO2001096373A3 (en) | Fluorescent timer proteins and methods for their use | |
| WO2004102198A3 (en) | Selection of b cells with specificity of interest: method of preparation and use | |
| DE60126482D1 (de) | Einkettige antikörper gegen eine p53 mutante | |
| WO2006073971A3 (en) | Binding protein with a scaffold for varying specificity | |
| Stutz et al. | Coupling brain perfusion screens and next generation sequencing to identify blood–brain barrier binding antibodies | |
| JP2021503292A (ja) | ｍＲＮＡディスプレイ抗体ライブラリー及び方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |